{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:21Z","timestamp":1789146801293,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urology.2026.07.047","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:32:49Z","timestamp":1786059169000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Urinary Peptide Signatures Distinguish Overactive Bladder and Are Associated With Improvement in Incontinence Following Therapy"],"prefix":"10.1016","volume":"215","author":[{"given":"Aaron W.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy H.","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip P.","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-672X","authenticated-orcid":false,"given":"Glenn T.","family":"Werneburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.07.047_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1532-5415.2011.03492.x","article-title":"Prevalence and effect on health-related quality of life of overactive bladder in older Americans: results from the epidemiology of lower urinary tract symptoms study","volume":"59","author":"Sexton","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urology.2026.07.047_bib2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/nau.25379","article-title":"How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI-RS 2023\u2014Part 2","volume":"43","author":"Finazzi Agr\u00f2","year":"2024","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.07.047_bib3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","article-title":"A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment","volume":"75","author":"Peyronnet","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.07.047_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2015.10.010","article-title":"The role of urinary peptidomics in kidney disease research","volume":"89","author":"Klein","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.urology.2026.07.047_bib5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1373\/clinchem.2013.211714","article-title":"Peptidomics of urine and other biofluids for cancer diagnostics","volume":"60","author":"Bau\u00e7a","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.urology.2026.07.047_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/nau.70227","article-title":"Urinary fungal microbiome and associations with overactive bladder, antibiotics and therapy response","volume":"45","author":"Werneburg","year":"2026","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.07.047_bib7","first-page":"10","article-title":"Urinary microbiome and metabolome differentiate overactive bladder from the physiological state, and reflect recent antibiotic use and treatment response","volume":"1097","author":"Werneburg","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.07.047_bib8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","article-title":"Using MetaboAnalyst 5.0 for LC\u2013HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data","volume":"17","author":"Pang","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.urology.2026.07.047_bib9","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/jcm10112446","article-title":"Characteristics of the urinary proteome in women with overactive bladder syndrome: a case-control study","volume":"10","author":"Koch","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.urology.2026.07.047_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/865463","article-title":"Evidence for bladder urothelial pathophysiology in functional bladder disorders","volume":"2014","author":"Keay","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.urology.2026.07.047_bib11","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/nau.24313","article-title":"Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI-RS 2019","volume":"39","author":"Speich","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.07.047_bib12","article-title":"Oxidative stress: a putative link between lower urinary tract symptoms and aging and major chronic diseases","volume":"9","author":"Xu","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.urology.2026.07.047_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/ene.13952","article-title":"Urogenital symptoms in mitochondrial disease: overlooked and undertreated","volume":"26","author":"Poole","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.urology.2026.07.047_bib14","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/nau.24479","article-title":"Lower urinary tract dysfunction in adult patients with mitochondrial disease","volume":"39","author":"Feeney","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.07.047_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00192-019-04175-6","article-title":"Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population","volume":"31","author":"Mossa","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2026.07.047_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.juro.2009.08.103","article-title":"Oxidative modification of mitochondrial integrity and nerve fiber density in the ischemic overactive bladder","volume":"183","author":"Azadzoi","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.07.047_bib17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/biom14091044","article-title":"Investigating the impact of estrogen levels on voiding characteristics, bladder structure, and related proteins in a mouse model of menopause-induced lower urinary tract symptoms","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.urology.2026.07.047_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction","volume":"62","author":"Robinson","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.07.047_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/GME.0000000000002187","article-title":"Menopause hormone therapy and urinary symptoms: a systematic review","volume":"30","author":"Christmas","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.urology.2026.07.047_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2025.103337","article-title":"Sacral neuromodulation for low urinary tract dysfunction: overview and mechanisms of action","volume":"261","author":"Dequirez","year":"2025","journal-title":"Auton Neurosci"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:51:14Z","timestamp":1789145474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S0090429526005054"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.07.047","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary Peptide Signatures Distinguish Overactive Bladder and Are Associated With Improvement in Incontinence Following Therapy","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}